Fiona Elizabeth Legere

Known for her highly personable and pragmatic approach, Fiona is a trusted advisor to many pharmaceutical and technology companies. She has managed and coordinated multi-jurisdictional patent enforcement actions and successfully acted as counsel in groundbreaking patent cases, including the first biologics case and non-practising entity (NPE) case in Canada.

Fiona has an impressive track record of successfully representing many clients in court proceedings, including before the Ontario Superior Court, the Ontario Court of Appeal, the Federal Court of Canada and the Federal Court of Appeal.

Fiona also has clients who rely on her to negotiate complex strategic settlements and business agreements with a keen eye for ensuring positive outcomes.

EMD Serono in ongoing patent litigation involving the drug Mavenclad (cladribine)

Regeneron and Bayer in several ongoing patent infringement actions involving the blockbuster drug Eylea (aflibercept)

AbbVie in several ongoing patent infringement actions involving the blockbuster drug Humira (adalimumab), in which AbbVie was successful in finding that the formulation patent was valid and infringed ( AbbVie Corporation v. Jamp Pharma Corporation )